1887

Abstract

To facilitate the evaluation of vaccines against bovine herpesvirus type 1 (BHV-1), a cotton rat model of intranasal (i.n.) BHV-1 infection was established. Cotton rat lung cells were similar to bovine cells in their ability to support BHV-1 replication . Furthermore, i.n. inoculation of cotton rats with BHV-1 resulted in pulmonary lesions comparable to BHV-1 infection in cattle. Using this model, the potential of i.n. and gastrointestinal (g.i.) immunization was examined with recombinant human adenoviruses expressing glycoprotein D (gD) of BHV-1 to induce protective immunity against BHV-1.The replication-competent virus (gD-dE3) was more efficient than the replication-defective virus (gD-dE1E3) in inducing gD- specific antibody in the serum and in the respiratory tract. Furthermore, i.n. immunization with gD-dE3 stimulated antigen-specific antibody-secreting cells in the lung 12 weeks following immunization. Protection against BHV-1 challenge correlated with gD-specific antibody levels such that i.n. immunization with gD-dE3 conferred complete protection, while g.i. immunization conferred only partial protection of the lungs of most animals against BHV-1 challenge. In comparison, immunization with gD-dE1E3 by either route resulted in only a partial reduction of BHV-1 titre in the respiratory tract. The results obtained demonstrate that mucosal immunization with replication-competent recombinant adenovirus expressing gD of BHV-1 can induce immunity and protection against BHV-1 challenge.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-11-2933
1997-11-01
2022-05-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/11/9367381.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-11-2933&mimeType=html&fmt=ahah

References

  1. Babiuk L. A., L’ltalien J., van Drunen Littel van den Hurk S., Zamb T., Lawman M. J. P., Hughes G., Gifford G. A. 1987; Protection of cattle from bovine herpesvirus type 1 (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159:57–66
    [Google Scholar]
  2. Baca-Estrada M. E., Liang X., Babiuk L. A., Yoo D. 1995; Induction of mucosal immunity in cotton rats to hemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus. Immunology 86:134–140
    [Google Scholar]
  3. Both G. W., Lockett L. J., Janardhana V., Edwards S. J., Bellamy A. R., Graham F. L., Prevec L. 1993; Protective immunity to rotavirus- induced diarrhoea is passively transferred to new-born mice from naive dams vaccinated with a single-dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193:940–950
    [Google Scholar]
  4. Breker-Klassen M. M., Yoo D., Mittal S. K., Sorden S. D., Haines D. M., Babiuk L. A. 1995; Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection. Journal of Virology 69:4308–4315
    [Google Scholar]
  5. Charlton K. M., Artois M., Prevec L., Campbell J. B., Casey G. A., Wandeler A. I., Armstrong J. 1992; Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Archives of Virology 123:169–179
    [Google Scholar]
  6. Chengalvala M. V., Bhat B. M., Bhat R. A., Dheer S. K., Lubeck M. D., Purcell R. H., Murthy K. K. 1997; Replication and immuno- genicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine 15:335–339
    [Google Scholar]
  7. Collins P. L., Prince G. A., Camargo E., Purcell R. H., Chanock R. M., Murphy B. R. 1990; Evaluation of the protective efficacy of recombinant vaccinia viruses and adenoviruses that express respiratory cyncytial virus glycoproteins. In Vaccines: Modern Approaches to New Vaccines including Prevention of AIDS pp. 79–84 Brown F., Chanock R. M., Ginsberg H., Lerner R. A. Edited by Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  8. Eloit M., Adam M. 1995; Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species. Journal of General Virology 76:1583–1589
    [Google Scholar]
  9. Eloit M., Gilardi-Hebenstreit P., Toma B., Perricaudet M. 1990; Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. Journal of General Virology 71:2425–2431
    [Google Scholar]
  10. Fooks A. R., Schadeck E., Liebert U. G., Dowsett A. B., Rima B. K., Steward M., Stephenson J. R., Wilkinson G. W. G. 1995; High- level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210:456–465
    [Google Scholar]
  11. Gallichan W. S., Johnson D. C., Graham F. L., Rosenthal K. L. 1993; Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. Journal of Infectious Diseases 168:622–629
    [Google Scholar]
  12. Gonin P., Oualikene W., Fournier A., Eloit M. 1996; Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice. Vaccine 14:1083–1087
    [Google Scholar]
  13. Graham F. L., Prevec L. 1992; Adenovirus-based expression vectors and recombinant vaccines. In Vaccines: New Approaches to Immunological Problems pp. 363–390 Ellis R. W. Edited by Massachus- setts: Butterworth-Heinemann;
    [Google Scholar]
  14. Haines D. M., Chelack B. J. 1991; Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. Journal of Veterinary Diagnostic Investigations 3:101–112
    [Google Scholar]
  15. Hsu K.-H.L., Lubeck M. D., Davis A. R., Bhat R. A., Selling B. H., Bhat B. M., Mizutani S., Murphy B. R., Collins P. L., Chanock R. M., Hung P. P. 1992; Immunogenicity of recombinant adenovirus- respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. Journal of Infectious Diseases 166:769–775
    [Google Scholar]
  16. Hsu K.-H.L., Lubeck M. D., Bhat B. M., Bhat R. A., Kostek B., Selling B. H., Mizutani S., Davis A. R., Hung P. P. 1994; Efficacy of adenovirus-vectored respiratory cyncytial virus vaccines in a new ferret model. Vaccine 12:607–612
    [Google Scholar]
  17. Huard J., Lochmuller H., Acsadi G., Jani A., Massie B., Karpati G. 1995; The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 2:107–115
    [Google Scholar]
  18. Hyland L., Sangster M., Sealy R., Coleclough C. 1994; Respiratory virus infection of mice provokes a permanent humoral immune response. Journal of Virology 68:6083–6086
    [Google Scholar]
  19. Imler J.-L. 1995; Adenovirus vectors as recombinant viral vaccines. Vaccine 13:1143–1151
    [Google Scholar]
  20. Jacobs S. C., Stephenson J. R., Wilkinson G. W. G. 1994; Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. Journal of General Virology 75:2399–2402
    [Google Scholar]
  21. Jericho K. W. F., Darcel C. l. Q. 1978; Response of the respiratory tract of calves kept at controlled climatic conditions to bovine herpesvirus 1 in aerosol. Canadian Journal of Comparative Medicine 42:156–167
    [Google Scholar]
  22. Kanesaki T., Murphy B. R., Collins P. L., Ogra P. L. 1991; Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. Journal of Virology 65:657–663
    [Google Scholar]
  23. Kraehenbuhl J.-P., Neutra M. R. 1994; Monoclonal secretory IgA for protection of the intestinal mucosa against viral and bacterial pathogens. In Handbook of Mucosal Immunology pp. 403–414 Ogra P. L., Mestecky J., Lamm M. E., Strober W., McGhee J. R., Bienenstock J. Edited by San Diego: Academic Press;
    [Google Scholar]
  24. Lubeck M. D., Davis A. R., Chengalvala M., Natuk R. J., Morin J. E., Molnar-Kimber K., Mason B. B., Bhat B. M., Mizutani S., Hung P. P., Purcell R. H. 1989; Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proceedings of the National Academy of Sciences, USA 866763–6767
    [Google Scholar]
  25. McNeal M. M., Ward R. L. 1995; Long -term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology 211:474–480
    [Google Scholar]
  26. Meitin C. A., Bender B. S., Small P. A. 1994; Enteric immunization of mice against influenza with recombinant vaccinia. Proceedings of the National Academy of Sciences, USA 9111187–11191
    [Google Scholar]
  27. Mestecky J., Abraham R., Ogra P. L. 1994; Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surfaces. In Handbook ofMucosal Immunology pp. 357–372 Ogra P. L., Mestecky J., Lamm M. E., Strober W., McGhee J. R., Bienenstock J. Edited by San Diego: Academic Press;
    [Google Scholar]
  28. Misra V., Blumenthal R. M., Babiuk L. A. 1981; Proteins specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). Journal of Virology 40:1046–1054
    [Google Scholar]
  29. Mittal S. K., Middleton D. M., Tikoo S. K., Babiuk L. A. 1995; Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology 213:131–139
    [Google Scholar]
  30. Mittal S. K., Papp Z., Tikoo S. K., Baca-Estrada M. E., Yoo D., Benko M., Babiuk L. A. 1996; Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222:299–309
    [Google Scholar]
  31. Morin J. E., Lubeck M. D., Barton J. E., Conley A. J., Davis A. R., Hung P. P. 1987; Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proceedings of the National Academy of Sciences, USA 84:4626–4630
    [Google Scholar]
  32. Murphy B. R. 1994; Mucosal immunity to viruses. In Handbook of Mucosal Immunology pp. 333–339 Ogra P. L., Mestecky J., Lamm M. E., Strober W., McGhee J. R., Bienenstock J. Edited by San Diego: Academic Press;
    [Google Scholar]
  33. Oualikene W., Gonin P., Eloit M. 1994; Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species. Journal of General Virology 75:2765–2768
    [Google Scholar]
  34. Pacini D. L., Dubovi E. J., Clyde W. A. 1984; A new animal model for human respiratory tract disease due to adenovirus. Journal of Infectious Diseases 150:92–97
    [Google Scholar]
  35. Porter D. D., Prince G. A., Hemming V. G., Porter H. G. 1991; Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats : Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia. Journal of Virology 65:103–111
    [Google Scholar]
  36. Prevec L., Schneider M., Rosenthal K. L., Belbeck L. W., Derbyshire J. B., Graham F. L. 1989; Use of human adenovirus-based vectors for antigen expression in animals. JournalofGeneral Virology 70:429–434
    [Google Scholar]
  37. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  38. Prince G. A., Jenson A. B., Horswood R. L., Camargo E., Chanock R. M. 1978; The pathogenesis ofrespiratory syncytial virus infection in cotton rats. American Journal of Pathology 93:771–792
    [Google Scholar]
  39. Prince G. A., Porter D. D., Jenson A. B., Horswood R. L., Chanock R. M., Ginsberg H. S. 1993; Pathog enesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). Journal of Virology 67:101–111
    [Google Scholar]
  40. Ragot T., Finerty S., Watkins P. E., Perricaudet M., Morgan A. J. 1993; Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. Journal of General Virology 74:501–507
    [Google Scholar]
  41. Rosenthal K. L., Copeland K. F. T., Gallichan W. S. 1996; Recombinant adenoviruses as vectors for mucosal immunity. In Mucosal Vaccines pp. 147–158 Kiyono H., Ogra P. L., McGhee J. R. Edited by San Diego: Academic Press;
    [Google Scholar]
  42. Slifka M. K., Ahmed R. 1996; Long -term humoral immunity against viruses : revisiting the issue of plasma cell longevity. Trends in Microbiology 4:394–400
    [Google Scholar]
  43. Tikoo S. K., Campos M., Babiuk L. A. 1995; Bovine herpesvirus 1 (BHV-1): biology, pathogenesis and control. Advances in Virus Research 45:191–219
    [Google Scholar]
  44. van Drunen Littel va nden Hurk S., Gifford G. A., Babiuk L. A. 1990; Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8:358–368
    [Google Scholar]
  45. van Drunen Littel van den Hurk S., Parker M. D., Massie B., vandenHurk J. V., Harland R., Babiuk L. A., Zamb T. J. 1993; Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11:25–35
    [Google Scholar]
  46. Xiang Z. Q., Yang Y., Wilson J. M., Ertl H. C. J. 1996; A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220–227
    [Google Scholar]
  47. Yates W. D. G. 1982; A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Canadian Journal of Comparative Medicine 46:225–263
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-11-2933
Loading
/content/journal/jgv/10.1099/0022-1317-78-11-2933
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error